Use of receiver-operator characteristic (ROC) curve analysis to evaluate predictors of response to clomipramine therapy
- PMID: 8927667
Use of receiver-operator characteristic (ROC) curve analysis to evaluate predictors of response to clomipramine therapy
Abstract
We used receiver-operator characteristic (ROC) curve analysis to evaluate predictors of response to clomipramine in obsessive-compulsive disorder (OCD). Previously, we identified response predictors among 230 OCD patients who received clomipramine in a placebo-controlled, multicenter clinical trail. We found that at baseline a later age of OCD onset, low scores on the Hamilton Depression scale, and high scores on items 3 and 8 of the Yale-Brown Obsessive Compulsive Scale predicted good response. Certain early side effects also predicted outcome. We fitted a logistic regression model containing baseline information and then calculated each patient's estimated response probability by substituting individuals' values in the regression equation. Next we compared the estimated response risks with each patient's known outcome. Finally, we produced a ROC curve by plotting the true positive and false positive rates for various cutoff points of the risk scores. The same steps were followed for Weeks 1 through 4, adding information about early side effects and weekly response. We found that baseline information predicted outcome better than chance, and predictive ability increased with data on side effects and early response.
Similar articles
-
Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.J Clin Psychopharmacol. 1994 Aug;14(4):247-54. J Clin Psychopharmacol. 1994. PMID: 7962680 Clinical Trial.
-
A predictive study of obsessive-compulsive disorder response to clomipramine.J Clin Psychopharmacol. 1993 Jun;13(3):210-3. J Clin Psychopharmacol. 1993. PMID: 8354737
-
Clinical features associated with treatment response in obsessive-compulsive disorder.Compr Psychiatry. 2006 Jul-Aug;47(4):276-81. doi: 10.1016/j.comppsych.2005.09.001. Epub 2006 Apr 19. Compr Psychiatry. 2006. PMID: 16769302
-
[Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].Encephale. 2000 Nov-Dec;26(6):73-83. Encephale. 2000. PMID: 11217541 French.
-
[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].Encephale. 2001 May-Jun;27(3):280-9. Encephale. 2001. PMID: 11488259 Review. French.
Cited by
-
Pharmacotherapeutic Strategies and New Targets in OCD.Curr Top Behav Neurosci. 2021;49:331-384. doi: 10.1007/7854_2020_204. Curr Top Behav Neurosci. 2021. PMID: 33751503 Free PMC article. Review.
-
Early improvement during manual-guided cognitive and dynamic psychotherapies predicts 16-week remission status.J Psychother Pract Res. 2001 Summer;10(3):145-54. J Psychother Pract Res. 2001. PMID: 11402077 Free PMC article.
-
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):851-859.e2. doi: 10.1016/j.jaac.2016.07.768. Epub 2016 Aug 4. J Am Acad Child Adolesc Psychiatry. 2016. PMID: 27663940 Free PMC article.
-
Does early non-improvement predict treatment failure in pharmacotherapy for obsessive-compulsive disorder? A diagnostic test accuracy meta-analysis with individual participant data.Psychol Med. 2025 Aug 15;55:e237. doi: 10.1017/S0033291725101335. Psychol Med. 2025. PMID: 40814277 Free PMC article.
-
Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120435. doi: 10.1098/rstb.2012.0435. Print 2013. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23440468 Free PMC article. Review.